Chemodex

Puerarin

CHF 177.00
In stock
CDX-P0250-M250250 mgCHF 177.00
More Information
Product Details
Synonyms Kakonein; NPI 031G; 8-(β-D-Glucopyranosyl-7-hydroxy-3- (4-hydroxyphenyl)-4H-1-benzopyran-4-one
Product Type Chemical
Properties
Formula C21H20O9
MW 416.38
CAS 3681-99-0
RTECS UO5216000
Source/Host Chemicals Isolated from plant source.
Purity Chemicals ≥98% (HPLC)
Appearance White to off white powder.
Solubility Soluble in DMSO (10mg/ml), DMF (10mg/ml), ethanol (5mg/ml) or methanol (1mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key HKEAFJYKMMKDOR-VPRICQMDSA-N
Smiles O=C1C(C2=CC=C(O)C=C2)=COC3=C([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(O)=CC=C31
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Puerarin is a natural isoflavone isolated from plants of the genus Pueraria used in traditional Chinese herbal medicine. Daidzein and glucuronides are the main metabolites of puerarin. It has been widely used in the treatment of cardiovascular and cerebrovascular diseases, diabetes and diabetic complications, osteonecrosis, Parkinson's disease, Alzheimer's disease, endometriosis, and cancer. The beneficial effects of puerarin on the various medicinal purposes may be due to its wide spectrum of pharmacological properties such as vasodilation, cardioprotection, neuroprotection, antioxidant, anticancer, anti-inflammation, alleviating pain, promoting bone formation, inhibiting alcohol intake and attenuating insulin resistance. Due to the poor water-solubility and liposolubility, the applications of puerarin are limited. Strategies to improve the bioavailability of puerarin are ongoing, various nanotechnologies and preparation technologies including microemulsions and SMEDDS, dendrimers, nanoparticles and nanocrystals have been researched to improve the bioavailability of puerarin. The neutrons dorsal motor nucleus of vagus (DMV) are important in the intestinal fat absorption. Inactivation of DMV neurons reduces intestinal fat absorption and consequently causes weight loss, whereas activation of the DMV increases fat absorption and weight gain. Puerarin mimics the suppression of the DMV pathway, which in turn leads to reduced fat absorption and weight loss. Puerarin works by binding to the receptor GABA A receptor.

Product References

(1) M.K. Choo, et al.; Biol. Pharm. Bull. 25, 1328 (2002) | (2) D.H. Overstreet, et al.; Pharm. Biochem. Beh. 75, 619 (2003) | (3) F.S. Chueh, et al.; J. Pharmacol. Sci. 96, 420 (2004) | (4) K. Nakamura, et al.; Chem. Pharm. Bull. 59, 23 (2011) | (5) S. Michihara, et al.; J. Nutr. Sci. Vitaminol. 58, 202 (2012) | (6) X.Y. Zhou, et al.; Phytother. Res. 28, 961 (2014) | (7) H.W. Jung, et al.; Nutrients 8, E33 (2017) | (8) H. Hongyun, et al.; Neurosci. Lett. 643, 45 (2017) | (9) M.Z. Int. Immunopharmacol. 61, 306 (2018) | (10) L. Zhang; Drug. Deliv. 26, 860 (2019) | (11) Y. Yi, et al.; J. Mol. Model 25, 202 (2019) | (12) D. Lian, et al.; Phytomedicine 55, 310 (2019) | (13) L. Jia, et al.; Exp. Ther. Med. 18, 543 (2019) | (14) G. Ye, et al.; Oncol. Lett. 17, 195 (2019) | (15) T. Liang, et al.; Mol. Biol. Rep. 46, 4787 (2019) | (16) Q. Lyu, et al.; Nature 634, 936 (2024)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.